AR018344A1 - Derivados de epotilona, procedimientos para su fabricacion y medicamentos y agentes de proteccion vegetal que los contienen - Google Patents
Derivados de epotilona, procedimientos para su fabricacion y medicamentos y agentes de proteccion vegetal que los contienenInfo
- Publication number
- AR018344A1 AR018344A1 ARP990102186A ARP990102186A AR018344A1 AR 018344 A1 AR018344 A1 AR 018344A1 AR P990102186 A ARP990102186 A AR P990102186A AR P990102186 A ARP990102186 A AR P990102186A AR 018344 A1 AR018344 A1 AR 018344A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- derivatives
- manufacturing
- alkyl
- epotilone
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000011814 protection agent Substances 0.000 title abstract 2
- 235000013311 vegetables Nutrition 0.000 title 1
- 125000004429 atom Chemical group 0.000 abstract 3
- 150000003883 epothilone derivatives Chemical class 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 229930013356 epothilone Natural products 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000003898 horticulture Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19820599A DE19820599A1 (de) | 1998-05-08 | 1998-05-08 | Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018344A1 true AR018344A1 (es) | 2001-11-14 |
Family
ID=7867085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102186A AR018344A1 (es) | 1998-05-08 | 1999-05-10 | Derivados de epotilona, procedimientos para su fabricacion y medicamentos y agentes de proteccion vegetal que los contienen |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6982280B1 (https=) |
| EP (1) | EP1077980B1 (https=) |
| JP (1) | JP2002514649A (https=) |
| KR (1) | KR20010052325A (https=) |
| AR (1) | AR018344A1 (https=) |
| AT (1) | ATE234842T1 (https=) |
| AU (1) | AU754212B2 (https=) |
| CA (1) | CA2330812A1 (https=) |
| DE (2) | DE19820599A1 (https=) |
| ES (1) | ES2195577T3 (https=) |
| HU (1) | HUP0102283A3 (https=) |
| IL (1) | IL139480A0 (https=) |
| TW (1) | TW568910B (https=) |
| WO (1) | WO1999058534A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| WO1999001124A1 (en) | 1996-12-03 | 1999-01-14 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| GB9810659D0 (en) | 1998-05-18 | 1998-07-15 | Ciba Geigy Ag | Organic compounds |
| US6518421B1 (en) | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
| SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
| DE10355223A1 (de) * | 2003-11-26 | 2005-06-30 | Institut für Pflanzenbiochemie (IPB) | Neue Makrocyclen zur Behandlung von Krebserkrankungen |
| EP1674098A1 (en) | 2004-12-23 | 2006-06-28 | Schering Aktiengesellschaft | Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water |
| EP2634252B1 (en) | 2005-02-11 | 2018-12-19 | University of Southern California | Method of expressing proteins with disulfide bridges |
| US20110104664A1 (en) | 2006-03-31 | 2011-05-05 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents |
| US8008256B2 (en) * | 2006-05-01 | 2011-08-30 | University Of Southern California | Combination therapy for treatment of cancer |
| EP2065054A1 (en) | 2007-11-29 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Combinations comprising a prostaglandin and uses thereof |
| DE102007059752A1 (de) | 2007-12-10 | 2009-06-18 | Bayer Schering Pharma Aktiengesellschaft | Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone |
| EP2070521A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Surface-modified nanoparticles |
| WO2010056901A2 (en) | 2008-11-13 | 2010-05-20 | University Of Southern California | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
| EP2210584A1 (en) | 2009-01-27 | 2010-07-28 | Bayer Schering Pharma Aktiengesellschaft | Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer |
| AU2011255647A1 (en) | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
| US9764038B2 (en) | 2011-12-23 | 2017-09-19 | Innate Pharma | Enzymatic conjugation of antibodies |
| WO2014009426A2 (en) | 2012-07-13 | 2014-01-16 | Innate Pharma | Screening of conjugated antibodies |
| US10036010B2 (en) | 2012-11-09 | 2018-07-31 | Innate Pharma | Recognition tags for TGase-mediated conjugation |
| EP2968582B1 (en) | 2013-03-15 | 2020-07-01 | Innate Pharma | Solid phase tgase-mediated conjugation of antibodies |
| EP3010547B1 (en) | 2013-06-20 | 2021-04-21 | Innate Pharma | Enzymatic conjugation of polypeptides |
| JP6744212B2 (ja) | 2013-06-21 | 2020-08-19 | イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． | ポリペプチドの酵素的結合 |
| WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| US5351146A (en) * | 1993-03-01 | 1994-09-27 | At&T Bell Laboratories | All-optical network architecture |
| US5781537A (en) * | 1995-07-07 | 1998-07-14 | International Business Machines Corporation | Setting up, taking down and maintaining connections in a communications network |
| DK1186606T4 (da) | 1995-11-17 | 2011-12-05 | Biotechnolog Forschung Gmbh | Epothilonderivater, deres fremstilling og anvendelse |
| DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
| DK1367057T3 (da) | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
| US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| US6304349B1 (en) * | 1998-06-30 | 2001-10-16 | Lucent Technologies Inc. | WDM optical communications networks and methods for provisioning |
| US6445844B1 (en) * | 1999-09-15 | 2002-09-03 | Xros, Inc. | Flexible, modular, compact fiber optic switch |
| US7092633B2 (en) * | 2000-11-14 | 2006-08-15 | University Of Texas System Board Of Regents | System and method for configuring optical circuits |
| US6982951B2 (en) * | 2000-12-21 | 2006-01-03 | At&T Corp. | Method for selecting a restoration path in a mesh network |
| US7212495B2 (en) * | 2001-02-21 | 2007-05-01 | Polytechnic University | Signaling for reserving a communications path |
| AU2002305113A1 (en) * | 2001-03-29 | 2002-10-15 | Atoga Systems, Inc. | Open ring architectures for optical wdm networks |
| US20020194339A1 (en) * | 2001-05-16 | 2002-12-19 | Lin Philip J. | Method and apparatus for allocating working and protection bandwidth in a telecommunications mesh network |
| AU2002351589A1 (en) * | 2001-06-27 | 2003-03-03 | Brilliant Optical Networks | Distributed information management schemes for dynamic allocation and de-allocation of bandwidth |
-
1998
- 1998-05-08 DE DE19820599A patent/DE19820599A1/de not_active Withdrawn
-
1999
- 1999-05-07 DE DE59904632T patent/DE59904632D1/de not_active Expired - Lifetime
- 1999-05-07 AT AT99926300T patent/ATE234842T1/de not_active IP Right Cessation
- 1999-05-07 KR KR1020007012437A patent/KR20010052325A/ko not_active Ceased
- 1999-05-07 IL IL13948099A patent/IL139480A0/xx unknown
- 1999-05-07 AU AU43611/99A patent/AU754212B2/en not_active Ceased
- 1999-05-07 EP EP99926300A patent/EP1077980B1/de not_active Expired - Lifetime
- 1999-05-07 WO PCT/EP1999/003159 patent/WO1999058534A2/de not_active Ceased
- 1999-05-07 CA CA002330812A patent/CA2330812A1/en not_active Abandoned
- 1999-05-07 US US09/674,877 patent/US6982280B1/en not_active Expired - Fee Related
- 1999-05-07 HU HU0102283A patent/HUP0102283A3/hu unknown
- 1999-05-07 JP JP2000548338A patent/JP2002514649A/ja not_active Withdrawn
- 1999-05-07 ES ES99926300T patent/ES2195577T3/es not_active Expired - Lifetime
- 1999-05-10 AR ARP990102186A patent/AR018344A1/es not_active Application Discontinuation
- 1999-05-14 TW TW088107412A patent/TW568910B/zh not_active IP Right Cessation
-
2004
- 2004-02-17 US US10/780,181 patent/US20040259922A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1077980B1 (de) | 2003-03-19 |
| EP1077980A2 (de) | 2001-02-28 |
| US20040259922A1 (en) | 2004-12-23 |
| KR20010052325A (ko) | 2001-06-25 |
| CA2330812A1 (en) | 1999-11-18 |
| AU754212B2 (en) | 2002-11-07 |
| ATE234842T1 (de) | 2003-04-15 |
| US6982280B1 (en) | 2006-01-03 |
| IL139480A0 (en) | 2001-11-25 |
| WO1999058534A3 (de) | 2000-01-13 |
| DE59904632D1 (de) | 2003-04-24 |
| HUP0102283A2 (hu) | 2001-10-28 |
| TW568910B (en) | 2004-01-01 |
| DE19820599A1 (de) | 1999-11-11 |
| WO1999058534A2 (de) | 1999-11-18 |
| JP2002514649A (ja) | 2002-05-21 |
| ES2195577T3 (es) | 2003-12-01 |
| HUP0102283A3 (en) | 2002-03-28 |
| AU4361199A (en) | 1999-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR018344A1 (es) | Derivados de epotilona, procedimientos para su fabricacion y medicamentos y agentes de proteccion vegetal que los contienen | |
| AR011984A1 (es) | Esteres diarilicos, procesos para su produccion, composiciones herbicidas que los comprenden, metodos para controlar malezas, metodo para desecar una planta, y compuestos intermediarios para producir dichos esteres. | |
| AR041724A1 (es) | Compuestos derivados de fenetanolamina y su utilizacion en composiciones farmaceuticas | |
| AR073130A1 (es) | Derivados de 5-bencil-4-azolilmetil-4-espiro [2.4] heptanol, metodos para producir los mismos y agentes agrohorticolas y agentes para proteger material industrial que los contienen. | |
| ES2054899T3 (es) | Derivados de 2'-desoxi-5-fluorouridina. | |
| CO5231190A1 (es) | Combinaciones de compuestos activos del tipo de los cetoenoles ciclicos con piretroides | |
| AR004195A1 (es) | Nuevos derivados de la 5-0 desosaminil-6-0-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios, metodo de aplicacionde los mismos para la preparacion de productos biologicamente activos. | |
| AR029821A1 (es) | Decahidro-isoquinolinas, un proceso para su preparacion, composiciones farmaceuticas que las comprenden y el uso de las mismas para la fabricacion de un medicamento | |
| ES8601893A1 (es) | Un procedimiento para preparar derivados de piridina susti- tuidos en las posiciones 2 y 6 | |
| GT200000049A (es) | Compuestos quimicos. | |
| UY26729A1 (es) | Alquilaminas heterocíclicas como antagonistas de los receptores muscarínicos | |
| MX9700297A (es) | Composiciones fungicidas a base de derivados de 3-fenil pirazoles para el tratamiento del material vegetal de reproduccion, nuevos derivados de 3-fenil-pirazoles y sus aplicaciones fungicidas. | |
| ECSP930981A (es) | Derivados de benzotiazol que tengan un substituto de difluorobuteniltio | |
| ES2159922T3 (es) | Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2058209T3 (es) | Derivados amidicos, procedimiento para su produccion y fungicidas agricola-horticolas que los contienen. | |
| DK0456209T3 (da) | Bis(alkylsubstituerede-4-hydroxyphenylthio)alkananaloger som inhibitorer af kataraktdannelse | |
| ES2038667T3 (es) | Metodo para producir un derivado de carbamato de yodo propargilo y composiciones fungicidas que lo contienen como ingrediente activo. | |
| ES2063065T3 (es) | Derivados de triazol, procedimiento para su preparacion y composiciones herbicidas que los contienen. | |
| AR040140A1 (es) | Derivados de esteres de camptotecina en la posicion 20 | |
| ES2090374T3 (es) | Derivados de tiazolina, procesos para su preparacion y composiciones plaguicidas que los contienen. | |
| AR023644A1 (es) | 3-aril-pirazoles substituidos, procedimiento para su obtencion, procedimiento para la lucha contra plantas indeseables, empleo de los mismos contra plantasindeseables y/o como fungicida, y composicion para el tratamiento de plantas | |
| MX9400163A (es) | Disulfonil metanos para el control de parasitos y formulaciones farmaceuticas que los contienen. | |
| ES2101823T3 (es) | Derivados benzo-1,2,3-tiadiazol. | |
| ES8704460A1 (es) | Un procedimiento para preparar derivados de 2-piridin-tiol | |
| BR8604300A (pt) | Compostos de fenoxi-ftalida,processo para a preparacao de um composto de fenoxi-ftalida,composicao herbicida e processo para combater plantas indesejadas em um determinado local |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FA | Abandonment or withdrawal |